Description
Research Areas
- Advanced dual amylin/GLP-1 combination research
- Body weight and fat mass reduction models
- Glycemic regulation across multiple pathways
$259.00
Higher-dose combination of Cagrilintide and Semaglutide for advanced dual-pathway metabolic research. Mirrors the CagriSema clinical formulation under study.
Phorm Labs
Research Areas
| Weight | .20 lbs |
|---|---|
| Dimensions | 7 × 4 × 3 in |
| Please Select | 10mg |
Reviews
There are no reviews yet.